CommentTreatment 2.0: catalysing the next phase of scale-up
References (12)
- et al.
Public financing of health in developing countries: a cross-national systematic analysis
Lancet
(2010) Treatment 2.0: Is this the future of treatment?
- et al.
A public health approach to antiretroviral therapy: overcoming constraints
2006 high-level meeting on AIDS: uniting the world against AIDS. Political declaration on HIV/AIDS
- et al.
Financing the response to AIDS in low- and middle-income countries: international assistance from the G8, European Commission and other donor governments in 2009
Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2010 revision
There are more references available in the full text version of this article.
Cited by (38)
Optimising the manufacture, formulation, and dose of antiretroviral drugs for more cost-efficient delivery in resource-limited settings: A consensus statement
2012, The Lancet Infectious DiseasesCitation Excerpt :The process for this conference involved independent experts, most of whom were not participants at our conference, discussing ways to incorporate principles of treatment optimisation into guidelines for first-line and second-line regimens for populations of adult and paediatric patients. Additional discussion included the recommendation to coordinate the directives of our conference with WHO treatment guidelines as part of its Treatment 2.0 initiative.21 Optimising APIs can reduce generic drug costs substantially.
HIV drug and supply stock-outs in Latin America
2011, The Lancet Infectious DiseasesFactors associated with loss to follow-up among women in Option B+ PMTCT programme in northeast Ethiopia: A retrospective cohort study
2016, Journal of the International AIDS SocietyEffectiveness and safety of combination of antiretroviral therapy in HIV-1 infected patients in western India
2016, International Journal of Pharmaceutical Research
Copyright © 2011 Elsevier Ltd. All rights reserved.